ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

In Brief: Henderson Chairs Reorganized NCA Centers Subcommittee; Core Grant Guidelines On Agenda

August 22, 1980

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998